Determine the effects of ERCP complications in patients receiving diclofenac suppository with patients receiving acetaminophen suppositories in patients with gallstones
Phase 2
- Conditions
- onsteroidal anti-inflammatory drugs.Other nonsteroidal anti-inflammatory drugs
- Registration Number
- IRCT2014020616504N1
- Lead Sponsor
- Vice Chancellor for Research of Mashhad University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 140
Inclusion Criteria
The main inclusion criteria to study: the need for ERCP (Endoscopic Retrograde Cholangiopancreatography) due to gallstones.
The main exclusion criteria from study: presence of coagulation disorders have already been diagnosed; Taking medications that may interfere with coagulation tests.
Exclusion Criteria
Not provided
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Bleeding rate. Timepoint: During ERCP and during 24 hours after ERCP. Method of measurement: Monitoring vital signs and clinical examination.
- Secondary Outcome Measures
Name Time Method